|
|
Volumn 6, Issue 7, 2009, Pages 371-
|
|
The most important news at ASCO 2009
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 (4 BROMO 2 CHLOROANILINO) 4 FLUORO 1 METHYL 1H BENZIMIDAZOLE 6 CARBOHYDROXAMIC ACID 2 HYDROXYETHYL ESTER;
MK 2206;
PROTEIN KINASE B INHIBITOR;
UNCLASSIFIED DRUG;
ENZYME INHIBITOR;
PROTEIN KINASE B;
CANCER CELL;
CELL SURVIVAL;
CONSENSUS DEVELOPMENT;
CYTOTOXICITY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
EDITORIAL;
INFORMATION PROCESSING;
NEOPLASM;
PRIORITY JOURNAL;
DRUG ANTAGONISM;
HUMAN;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
METHODOLOGY;
ORGANIZATION;
PHASE 1 CLINICAL TRIAL;
UNITED STATES;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS, PHASE I AS TOPIC;
CONGRESSES AS TOPIC;
DRUG APPROVAL;
ENZYME INHIBITORS;
HUMANS;
NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-AKT;
SOCIETIES, MEDICAL;
UNITED STATES;
|
|
EID: 70349560646
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2009.93 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|